Por: Fox Business Business September 30, 2022
Macro Trends Advisors LLC Founding Partner Mitch Roschelle and Former Trump senior economic adviser Steve Moore discuss tumbling stocks, large government deficits, lack of growth, and false signals on the market on 'Cavuto: Coast to Coast'. Here are the key events taking place on Friday NIKE RESULTS: Shares are down more than 9% in premarket trading after the company said inventories rose 44% to $9.7 billion in the latest quarter, and... + full article
New York Post USA Business October 01, 2022
Inflation-battered shoppers will soon find some huge deals on Nike products. The world’s biggest sportswear company said it was stuck with a glut of out-of-season inventory that will force it to mark down prices going into the all-crucial holiday period. Nike, based in... + más
Nike is going on sale, and its stock is plunging | CNN
Nike shares fall as overstocked inventory weighs on earnings | CNBC
CNN USA Business September 30, 2022
New York CNN Business — Add Nike to the list of brands and stores to clear it off shelves. Nike said Thursday its inventory levels soared 65% in North America, its largest market, and 44% overall last quarter from a year ago. After navigating in 2021 Nike is now carrying... + más
Nike to offer big discounts amid a glut of inventory | New York Post
Nike earnings preview: Why analysts are trimming profit forecasts | MarketWatch
ABC7 USA Health September 30, 2022
, has been approved by the US Food and Drug Administration.The FDA announced approval of Relyvrio, developed by Amylyx Pharmaceuticals, on Thursday. The oral medication can be taken as a standalone therapy or with other treatments, according to the company, and it has been shown... + más
Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post
ALS drug wins FDA approval despite questionable data | ABC News
ABC News USA Health September 30, 2022
WASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más
New York Post USA Life September 30, 2022
A much-debated drug for Lou Gehrig’s disease won US approval on Thursday from the Food and Drug Administration. The nod represents a long-desired victory for patients, though it is likely to renew questions about the scientific rigor behind government reviews of... + más
ALS drug gets FDA approval despite uncertainty about effectiveness | ABC7
PennLive USA Nation September 30, 2022
WASHINGTON — A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más
MarketWatch USA Business September 24, 2022
See also: With the U.S. economy faring relatively well and pushing the dollar higher as compared to other currencies, some analysts are trimming their estimates on Nike for the quarter or the year. Analysts at Credit Suisse said in research note Friday that they were lowering... + más
North Carolina woman prints her resume on a cake, has it delivered to Nike | 10 WBNS
Nike Postpones Next Travis Scott Drop as Houston Officials Decline 3rd Party Investigation Into Astroworld Tragedy | The Root
About iurex | Privacy Policy | Disclaimer |